Megan A. Chesnick

Papers

Total Citations

H-Index

About

Megan A. Chesnick is a leading researcher in the safety and efficiency of pharmacy operations, with a primary focus on the automation of antineoplastic preparation. Her most-cited work, "Impact of Robotic Antineoplastic Preparation on Safety, Workflow, and Costs" (2012, 73 citations), provides a landmark evaluation of how robotic systems can transform the compounding of hazardous drugs. In this study, Chesnick and her colleagues demonstrated that robotic antineoplastic preparation offers significant advantages over standard manual practices, including enhanced safety for pharmacy staff by reducing exposure to toxic agents, streamlined workflow, and potential cost savings. This research has been instrumental in guiding hospitals and cancer centers toward adopting automated solutions, directly influencing policy and practice in sterile compounding. Chesnick’s contributions are particularly notable for bridging the gap between clinical pharmacy and engineering, offering evidence-based insights that prioritize both worker safety and operational efficiency. Her work remains a foundational reference for pharmacists, administrators, and researchers seeking to modernize hazardous drug handling, making her a key figure in the ongoing evolution of safe, cost-effective pharmacy practice.